The multi-centre, multi-national study builds on existing U.S. PE Clearance and CE Mark to assess mechanical thrombectomy treatment and long-term functional outcomes in intermediate-risk PE patients across Europe AngioDynamics, Inc., a leading and transformative medical technology company focused on
ReGelTec has announced it has treated the first patient in its HYDRAFIL-D FDA investigational device exemption (IDE) clinical trial for its HYDRAFIL System for disc augmentation. The patient was enrolled by Kas Amirdelfan, M.D., an interventional pain physician and founding member of Boomerang Healt
Thanks to their unparalleled sensitivity, quantum sensors are poised to revolutionise various fields, from medical technology to autonomous navigation and renewable energies. These sensors are at the forefront of quantum technology, offering measurement capabilities that approach the theoretical lim
A fresh 6 billion GBP in funding available through the Horizon Europe programme could be ‘utterly transformative for healthcare innovation and net zero ambitions,’ says a formal NHS Scotland partner. InnoScot Health says it believes the recent funding announcement from the European Commission is hug
The University of Liverpool is leading a major 8.6 million EUR (7m GBP) EU-funded research project to tackle a growing medical challenge affecting thousands of cancer survivors: medication-related osteonecrosis of the jaw (MRONJ). The new project, GreenNanoBone, aims to prevent and treat this severe
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, sets out Government’s commitment to securing the invol
Researchers develop advanced contact lenses with stable MXene coatings providing enhanced protection against electromagnetic radiation. As the development of smart contact lenses is on the rise, concerns about radiation exposure and eye health continue to grow, posing potential risks such as catarac
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on a huge funding boost for microscopic resear
Aptamer Group plc, a leading developer of next-generation synthetic binders delivering innovation to the life science industry, has announced the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA), a format widely accepted and us
A dangerous hospital superbug is found to digest plastic – specifically the kind used in some sutures, stents and implants inside the human body. Microbiologists at Brunel University of London show the bacteria can ‘feed’ on plastic to survive, potentially enabling these pathogens to survive longer
QV Bioelectronics, developer of an implanted Electric Field Therapy (EFT) device for brain tumours, has announced it has been awarded a 1.26 million GBP grant under the Biomedical Catalyst programme. The funding will support key technical and regulatory milestones to prepare for QV’s first-in-human
Dxcover Limited, a clinical-stage diagnostics company pioneering its multiomic spectral analysis (MOSA-Dx) for early detection of solid tumour cancers, has announced the presentation of real-world data showing, for the first time, a clear and consistent association between increased tumour size and
